Previous Close | 310.80 |
Open | 310.60 |
Bid | 309.70 x N/A |
Ask | 310.20 x N/A |
Day's Range | 305.30 - 310.90 |
52 Week Range | 191.30 - 353.80 |
Volume | |
Avg. Volume | 756,288 |
Market Cap | 367.506B |
Beta (5Y Monthly) | 1.23 |
PE Ratio (TTM) | 232.48 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.60 (1.16%) |
Ex-Dividend Date | Nov 29, 2024 |
1y Target Est | N/A |
Skincare company Galderma was on course to raise 2.3 billion ($2.6 billion) Swiss francs from its upcoming initial public (IPO) offering after a positive response from potential investors. The company, whose products includes Cetaphil, a product for damaged and sensitive skin, as well as fillers and skin creams, early on Wednesday announced a price range of 49 to 53 Swiss francs for its flotation - likely to be one of the biggest in Europe this year. The offering consists of up to 40.5 million new shares and 277,000 existing shares, the company said.
Hotelbeds is interviewing banks to lead the sale of more than 1 billion euros ($1.07 billion) of shares in an initial public offering (IPO) next year, people familiar with the matter told Reuters. The Spanish travel technology firm, advised by Evercore , is poised to appoint a couple of banks as global coordinators alongside Morgan Stanley after recently inviting pitches, said the people, who spoke on the condition of anonymity. The company and its shareholders – which include private equity funds Cinven and EQT, as well as Canadian pension plan CPP Investments – are leaning towards Madrid as their preferred listing venue, one of them said.